RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    유비퀴틴화에 의한 세포 내 p53의 기능 조절

    한글로보기

    https://www.riss.kr/link?id=A100422173

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    국문 초록 (Abstract) kakao i 다국어 번역

    p53은 전사인자로서 세포의 사멸이나 세포주기 조절 등 다양한 세포 활성을 보이기 때문에 일반적인 환경에서는 매우 낮은 수준으로 단백질 양이 확인된다. p53의 단백질 양과 활성은 다양한 세포 내 신호에 의하여 이루어지는 후전사 변형을 통하여 조절 받는다. 이중 유비퀴틴화는 세포 내에서 p53 단백질의 발현 수준이 낮게 유지되는 것이 가능하게 하는 대표적인 기전이다. 이러한 기전을 일으키는 대표적인 p53의 E3 ligase로는 mdm2, Pirh2, COP1, ARF-BP1 등이 보고되어 있으며, 각각 negative feedback loop나 다른 기전을 통하여 p53 단백질의 분해를 유도하여 세포의 항상성을 조절한다. 이 밖에도 p53은 mdm2나 WWP1, UBC13, MSL2와 같은 E3 ligase로 인해서 모노 유비퀴틴화 되고, p53의 세포 내 위치가 조절되어 전사인 자로서의 활성이 억제된다. p53의 세포 내 위치와는 관계 없이 53의 전사인자로써의 활성 또한 아세틸화와 유비퀴 틴화의 경쟁적 반응으로 인해 조절 될 수 있다. E4F1에 의한 유비퀴틴화는 세포주기와 관련된 유전자의 발현을 증가시키되 세포사멸 관련 유전자의 발현은 감소시키는 것으로 보아 p53의 수많은 downstream gene의 발현 또한 유비퀴틴화를 통해 조절 될 수 있음이 제시되었다. 앞으로의 연구는 신규 E3 ligase에 의한 p53의 유비퀴틴화 기전 연구 뿐 아니라 이와 관련된 다른 변형과의 관계에 대한 연구 또한 매우 중요하게 부각되어 질 것으로 예상된다.
    번역하기

    p53은 전사인자로서 세포의 사멸이나 세포주기 조절 등 다양한 세포 활성을 보이기 때문에 일반적인 환경에서는 매우 낮은 수준으로 단백질 양이 확인된다. p53의 단백질 양과 활성은 다양한 ...

    p53은 전사인자로서 세포의 사멸이나 세포주기 조절 등 다양한 세포 활성을 보이기 때문에 일반적인 환경에서는 매우 낮은 수준으로 단백질 양이 확인된다. p53의 단백질 양과 활성은 다양한 세포 내 신호에 의하여 이루어지는 후전사 변형을 통하여 조절 받는다. 이중 유비퀴틴화는 세포 내에서 p53 단백질의 발현 수준이 낮게 유지되는 것이 가능하게 하는 대표적인 기전이다. 이러한 기전을 일으키는 대표적인 p53의 E3 ligase로는 mdm2, Pirh2, COP1, ARF-BP1 등이 보고되어 있으며, 각각 negative feedback loop나 다른 기전을 통하여 p53 단백질의 분해를 유도하여 세포의 항상성을 조절한다. 이 밖에도 p53은 mdm2나 WWP1, UBC13, MSL2와 같은 E3 ligase로 인해서 모노 유비퀴틴화 되고, p53의 세포 내 위치가 조절되어 전사인 자로서의 활성이 억제된다. p53의 세포 내 위치와는 관계 없이 53의 전사인자로써의 활성 또한 아세틸화와 유비퀴 틴화의 경쟁적 반응으로 인해 조절 될 수 있다. E4F1에 의한 유비퀴틴화는 세포주기와 관련된 유전자의 발현을 증가시키되 세포사멸 관련 유전자의 발현은 감소시키는 것으로 보아 p53의 수많은 downstream gene의 발현 또한 유비퀴틴화를 통해 조절 될 수 있음이 제시되었다. 앞으로의 연구는 신규 E3 ligase에 의한 p53의 유비퀴틴화 기전 연구 뿐 아니라 이와 관련된 다른 변형과의 관계에 대한 연구 또한 매우 중요하게 부각되어 질 것으로 예상된다.

    더보기

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    p53 undergoes various post-translational modifications, including phosphorylation, ubiquitination, sumoylation, acetylation, methylation, and poly(ADP-ribosyl)ation. Modification of p53 widely affects to various functions of p53. Acetylation and phosphorylation of p53 have been studied for regulating its transcriptional activity which is observed in various stress condition. Otherwise, ubiquitination of p53 by Mdm2 has been well-studied as a canonical ubiquitin-mediated proteasomal degradation pathway. Moreover several investigators have recently reported that ubiquitination of p53 modulates not only its proteasome-dependent degradation by oly-ubiquitination but also its localization and transcriptional activity by mono-ubiquitination which usually does not serve the proteasome dependent degradation. Here we review recent studies on the cellular functions of p53 regulated by post-translational modifications, particularly focusing on mechanisms of ubiquitination.
    번역하기

    p53 undergoes various post-translational modifications, including phosphorylation, ubiquitination, sumoylation, acetylation, methylation, and poly(ADP-ribosyl)ation. Modification of p53 widely affects to various functions of p53. Acetylation and phosp...

    p53 undergoes various post-translational modifications, including phosphorylation, ubiquitination, sumoylation, acetylation, methylation, and poly(ADP-ribosyl)ation. Modification of p53 widely affects to various functions of p53. Acetylation and phosphorylation of p53 have been studied for regulating its transcriptional activity which is observed in various stress condition. Otherwise, ubiquitination of p53 by Mdm2 has been well-studied as a canonical ubiquitin-mediated proteasomal degradation pathway. Moreover several investigators have recently reported that ubiquitination of p53 modulates not only its proteasome-dependent degradation by oly-ubiquitination but also its localization and transcriptional activity by mono-ubiquitination which usually does not serve the proteasome dependent degradation. Here we review recent studies on the cellular functions of p53 regulated by post-translational modifications, particularly focusing on mechanisms of ubiquitination.

    더보기

    목차 (Table of Contents)

    • Abstract
    • 서론
    • Ubiquitination을 통한 p53의 분해 조절 기전
    • 유비퀴틴화를 통한 세포 내 p53의 위치 변화
    • 유비퀴틴화를 통한 p53의 전사인자 활성 조절
    • Abstract
    • 서론
    • Ubiquitination을 통한 p53의 분해 조절 기전
    • 유비퀴틴화를 통한 세포 내 p53의 위치 변화
    • 유비퀴틴화를 통한 p53의 전사인자 활성 조절
    • 요약
    • REFERENCES
    더보기

    참고문헌 (Reference)

    1 Dulic, V., "p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiationinduced G1 arrest" 76 : 1013-1023, 1994

    2 Brooks, C. L., "p53 ubiquitination: Mdm2 and beyond" 21 : 307-315, 2006

    3 Budhram-Mahadeo, V., "p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor" 274 : 15237-15244, 1999

    4 Liu, L., "p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage" 19 : 1202-1209, 1999

    5 Hollstein, M., "p53 mutations in human cancers" 253 : 49-53, 1991

    6 Lowe, S. W., "p53 is required for radiation-induced apoptosis in mouse thymocytes" 362 : 847-849, 1993

    7 Giannakakou, P., "p53 is associated with cellular microtubules and is transported to the nucleus by dynein" 2 : 709-719, 2000

    8 Mihara, M., "p53 has a direct apoptogenic role at the mitochondria" 11 : 577-590, 2003

    9 Baker, S. J., "p53 gene mutation occur in combination with 17p allelic deletions as late events in cololectal tumorigenesis" 23 : 717-722, 1990

    10 Grossman, S. R., "p300/MDM2 complexes participate in MDM2-mediated p53 degradation" 2 : 405-415, 1998

    1 Dulic, V., "p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiationinduced G1 arrest" 76 : 1013-1023, 1994

    2 Brooks, C. L., "p53 ubiquitination: Mdm2 and beyond" 21 : 307-315, 2006

    3 Budhram-Mahadeo, V., "p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor" 274 : 15237-15244, 1999

    4 Liu, L., "p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage" 19 : 1202-1209, 1999

    5 Hollstein, M., "p53 mutations in human cancers" 253 : 49-53, 1991

    6 Lowe, S. W., "p53 is required for radiation-induced apoptosis in mouse thymocytes" 362 : 847-849, 1993

    7 Giannakakou, P., "p53 is associated with cellular microtubules and is transported to the nucleus by dynein" 2 : 709-719, 2000

    8 Mihara, M., "p53 has a direct apoptogenic role at the mitochondria" 11 : 577-590, 2003

    9 Baker, S. J., "p53 gene mutation occur in combination with 17p allelic deletions as late events in cololectal tumorigenesis" 23 : 717-722, 1990

    10 Grossman, S. R., "p300/MDM2 complexes participate in MDM2-mediated p53 degradation" 2 : 405-415, 1998

    11 Tanaka, T., "hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes" 130 : 638-650, 2007

    12 Dias, S. S., "c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF" 25 : 6666-6671, 2006

    13 Yonish-Rouach, E., "Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6" 352 : 345-347, 1991

    14 Owen-Schaub, L. B., "Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression" 15 : 3032-3040, 1995

    15 el-Deiry, W. S., "WAF1/ CIP1 is induced in p53-mediated G1 arrest and apoptosis" 54 : 1169-1174, 1994

    16 Chan, W. M., "Ubiquitination of p53 at multiple sites in the DNA-binding domain" 4 : 15-25, 2006

    17 Guan, B., "Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1" 283 : 4834-4840, 2008

    18 Foo, R. S., "Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2" 282 : 5529-5535, 2007

    19 Hochstrasser, M., "Ubiquitin-dependent protein degradation" 30 : 405-439, 1996

    20 Fakharzadeh, S. S., "Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line" 10 : 1565-1569, 1991

    21 Miyashita, T., "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene" 80 : 293-299, 1995

    22 Rajendra, R., "Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53" 279 : 36440-36444, 2004

    23 Hershko, A., "The ubiquitin system for protein degradation" 61 : 761-807, 1992

    24 Dornan, D., "The ubiquitin ligase COP1 is a critical negative regulator of p53" 429 : 86-92, 2004

    25 Middeler, G., "The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energydependent and lectin-inhibited" 14 : 1407-1417, 1997

    26 Ogryzko, V. V., "The transcriptional coactivators p300 and CBP are histone acetyltransferases" 87 : 953-959, 1996

    27 Osterlund, M. T., "The role of COP1 in repression of Arabidopsis photomorphogenic development" 9 : 113-118, 1999

    28 Wu, X., "The p53-mdm-2 autoregulatory feedback loop" 7 : 1126-1132, 1993

    29 Boddy, M. N., "The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger" 19 : 198-199, 1994

    30 Boutell, C., "The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and ubiquitinates p53" 278 : 36596-36602, 2003

    31 Moriuchi, H., "The RING finger domain of the varicella-zoster virus open reading frame 61 protein is required for its transregulatory functions" 205 : 238-246, 1994

    32 Geyer, R. K., "The MDM2 RING-finger domain is required to promote p53 nuclear export" 2 : 569-573, 2000

    33 Scheffner, M., "The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53" 63 : 1129-1136, 1990

    34 Itahana, K., "Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation" 12 : 355-366, 2007

    35 McDonald, E. R. 3rd, "Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth" 6170-6175, 2004

    36 Shaulsky, G., "Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells" 5 : 1707-1711, 1990

    37 Mayr, G. A., "Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation" 55 : 2410-2417, 1995

    38 Buschmann, T., "SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53" 101 : 753-762, 2000

    39 Von Arnim, A. G., "Ring finger motif of Arabidopsis thaliana COP1 defines a new class of zinc-binding domain" 268 : 19626-19631, 1993

    40 Jones, S. N., "Rescue of embryonic lethality in Mdm2- deficient mice by absence of p53" 378 : 206-208, 1995

    41 Montes, de Oca Luna R., "Rescue of early embryonic lethality in mdm2- deficient mice by deletion of p53" 378 : 203-206, 1995

    42 Laine, A., "Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1" 26 : 1477-1483, 2007

    43 Laine, A., "Regulation of p53 localization and activity by Ubc13" 26 : 8901-8913, 2006

    44 Thrower, J. S., "Recognition of the polyubiquitin proteolytic signal" 19 : 94-10, 2000

    45 Khosravi, R., "Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage" 14973-14977, 1999

    46 Grossman, S. R., "Polyubiquitination of p53 by a ubiquitin ligase activity of p300" 300 : 342-344, 2003

    47 Leng, R. P., "Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation" 112 : 779-791, 2003

    48 Hattori, T., "Pirh2 promotes ubiquitin-dependent degradation of the cyclindependent kinase inhibitor p27Kip1" 67 : 10789-10795, 2007

    49 Duan, S., "Phosphorylation of Pirh2 by calmodulindependent kinase II impairs its ability to ubiquitinate p53" 26 : 3062-3074, 2007

    50 Nikolaev, A. Y., "Parc: a cytoplasmic anchor for p53" 112 : 29-40, 2003

    51 Nakano, K., "PUMA, a novel proapoptotic gene, is induced by p53" 7 : 683-694, 2001

    52 Roth, J., "Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein" 17 : 554-564, 1998

    53 Shaulsky, G., "Nuclear localization is essential for the activity of p53 protein" 6 : 2055-2065, 1991

    54 Freedman, D. A., "Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6" 18 : 7288-7293, 1998

    55 Joseph, T. W., "Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage" 17 : 1622-1630, 2003

    56 Shaulsky, G., "Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis" 10 : 6565-6577, 1990

    57 Oda, E., "Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis" 288 : 1053-1058, 2000

    58 Colaluca, I. N., "NUMB controls p53 tumour suppressor activity" 451 : 76-80, 2008

    59 Hsu, I. C., "Mutational hotspot in the p53 gene in human hepatocellular carcinomas" 350 : 427-428, 1991

    60 Zhong, Q., "Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis" 121 : 1085-1095, 2005

    61 Marchenko, N. D., "Monoubiquitylation promotes mitochondrial p53 translocation" 26 : 923-934, 2007

    62 Li, M., "Mono-versus polyubiquitination: differential control of p53 fate by Mdm2" 302 : 1972-1975, 2003

    63 Sheng, Y., "Molecular basis of Pirh2-mediated p53 ubiquitylation" 15 : 1334-1342, 2008

    64 Ofir-Rosenfeld, Y., "Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26" 32 : 180-189, 2008

    65 Kojima, K., "Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcriptiondependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia" 108 : 993-1000, 2006

    66 Barak, Y., "Mdm2 expression is induced by wild type p53 activity" 12 : 461-468, 1993

    67 Mullen, M. A., "Mapping of intracellular localization domains and evidence for colocalization interactions between the IE110 and IE175 nuclear transactivator proteins of herpes simplex virus" 68 : 3250-3266, 1994

    68 Kruse, J. P, "MSL2 promotes MDM2 independent cytoplasmic localization of p53" 2008

    69 Pan, Y., "MDM2 promotes ubiquitination and degradation of MDMX" 23 : 5113-5121, 2003

    70 Paulin, F. E., "MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism" 8 : 281-, 2008

    71 Bond, G. L., "MDM2 SNP 309 accelerates tumor formation in a gender-specific and hormone-dependent manner" 66 : 5104-5110, 2006

    72 Oh, W., "Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2" 281 : 17457-17465, 2006

    73 Jr Haluska, P., "Interaction between human topoisomerase I and a novel RING finger/ arginine-serine protein" 27 : 2538-2544, 1999

    74 Vassilev, L. T., "In vivo activation of the p53 pathway by smallmolecule antagonists of MDM2" 303 : 844-848, 2004

    75 Sidransky, D., "Identification of p53 gene mutations in bladder cancers and urine samples" 252 : 706-709, 1991

    76 Das, S., "Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation" 130 : 624-637, 2007

    77 I. R. Logan, "Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer" 26 : 6502-6510, 2006

    78 Weake, V. M., "Histone ubiquitination: triggering gene activity" 29 : 653-663, 2008

    79 Diao, L., "Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination" 17 : 217-229, 2005

    80 Bond, J., "Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence" 13 : 2097-2104, 1996

    81 Yang, J. Y., "ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation" 10 : 138-148, 2008

    82 Le Cam, L., "E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation" 127 : 775-788, 2006

    83 Stacey, M. G., "Discrete domains mediate the light-responsive nuclear and cytoplasmic localization of Arabidopsis COP1" 11 : 349-364, 1999

    84 Lain, S., "Discovery, in vivo activity, and mechanism of action of a smallmolecule p53 activator" 13 : 454-463, 2008

    85 Li, M., "Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization" 416 : 648-653, 2002

    86 Li, M., "Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization" 416 : 648-653, 2002

    87 Crighton, D., "DRAM, a p53-induced modulator of autophagy, is critical for apoptosis" 126 : 121-134, 2006

    88 Shieh, S. Y., "DNA damage-induced phosphory lation of p53 alleviates inhibition by MDM2" 91 : 325-334, 1997

    89 Siliciano, J. D., "DNA damage induces phosphorylation of the amino terminus of p53" 11 : 3471-3481, 1997

    90 Courjal, F., "DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours" 74 : 1984-1989, 1996

    91 Andrews, P., "Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function" 25 : 4534-4548, 2006

    92 Yamasaki, S., "Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquuitin ligase Synoviolin" 26 : 113-122, 2007

    93 Murray, A, "Cyclin ubiquitination: the destructive end of mitosis" 81 : 149-152, 1995

    94 Logan, I. R., "Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome" 279 : 11696-11704, 2004

    95 Xu, P., "Characterization of polyubiquitin chain structure by middle-down mass spectrometry" 80 : 3438-3444, 2008

    96 O’Connor, M. J., "Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300" 73 : 3574-3581, 1999

    97 Lane, D. P., "Cancer. p53, guardian of the genome" 358 : 15-16, 1992

    98 Kato, S., "COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression" 283 : 35464-35473, 2008

    99 Yang, W., "CARPs are ubiquitin ligases that promote MDM2-independent p53 and phospho-p53ser20 degradation" 282 : 3273-3281, 2007

    100 Liao W, "CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation" 18 : 641-649, 2008

    101 Lohrum, M. A., "C-terminal ubiquitination of p53 contributes to nuclear export" 21 : 8521-8532, 2001

    102 Carter, S., "C-terminal modifications regulate MDM2 dissociation and nuclear export of p53" 9 : 428-435, 2007

    103 Honda, R., "Association of p19 (ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53" 18 : 22-27, 1999

    104 Gu, W., "Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain" 90 : 595-606, 1997

    105 Sykes, S. M., "Acetylation of the p53 DNA-binding domain regulates apoptosis induction" 24 : 841-851, 2006

    106 Barlev, N. A., "Acetylation of p53 activates transcription through recruitm ent of coactivators/histone acetyltransferases" 8 : 1243-1254, 2001

    107 Tang, Y., "Acetylation is indispensable for p53 activation" 133 : 612-626, 2008

    108 Vaziri, H., "ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase" 16 : 6018-6033, 1997

    109 Dornan, D., "ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage" 313 : 1122-1126, 2006

    110 Chen, D., "ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor" 121 : 1071-1083, 2005

    111 Zhang, Y., "ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways" 92 : 725-734, 1998

    112 Hu, W., "A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells" 67 : 2757-2765, 2007

    113 Mayo, L. D., "A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus" 11598-11603, 2001

    114 Hou, Y., "A new class of Arabidopsis constitutive photomorphogenic genes involved in regulating cotyledon development" 5 : 329-339, 1993

    115 Chau, V., "A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein" 243 : 1576-1583, 1989

    116 Kastan, M. B., "A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia" 71 : 587-597, 1992

    117 Stommel, J. M., "A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking" 18 : 1660-1672, 1999

    118 Terrell, J., "A function for monoubiquitination in the internalization of a G protein-coupled receptor" 1 : 193-202, 1998

    119 Canning, M., "A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7" 279 : 38160-38168, 2004

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2022 평가 재인증평가 신청대상 (재인증)
    2019-01-01 등재 등재학술지 유지 (계속평가) KCI등재
    2016-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2015-12-01 등재 등재후보로 하락 (기타) KCI등재후보
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-08-28 학술지명변경 한글명 : 한국생물공학회지 -> KSBB Journal
    외국어명 : Korean Journal of Biotechnology and Bioengineering -> Korean Society for Biotechnology and Bioengineering Journal
    KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2007-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2005-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2002-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    1999-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.37 0.37 0.38
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.37 0.36 0.662 0.02
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼